At the beginning of 2015, we jointly obtained the CEP certificate for Diosmin issued by the European Agency for Drug Quality (EDQM).

    CEP certificate (Certificate of Suitability) refers to the European Pharmacopoeia applicability certification, which aims to investigate whether the European Pharmacopoeia can effectively control the quality of imported drugs. It is another registration method for the legitimate use of API by EU end users. Obtaining the CEP certificate indicates that our Diosmin products have been further recognized by European authorities, providing more convenience for them to enter the European market.